Skip to main content
. 2020 Jul 24;62:e52. doi: 10.1590/S1678-9946202062052

Table 4. Risk of negative PCR results before and after benznidazole treatment.

  • Study

  • Before

  • After

  • Weight

  • RR

  • 95% CI

 

  • Events

  • Total

  • Events

  • Total

  • Alvarez et al.6

  • Oliveira et al.16

  • Pérez Antón et al.19

  • Pinazo et al.29

  • Vallejo et al.33

  • Total (95% CI)

  • Total events

  • 6

  • 0

  • 18

  • 40

  • 0

  • 64

  • 17

  • 21

  • 38

  • 56

  • 7

  • 139

  • 16

  • 16

  • 38

  • 55

  • 7

  • 132

  • 17

  • 21

  • 38

  • 56

  • 7

  • 139

  • 25.4%

  • 4.8%

  • 31.4%

  • 41.2%

  • 5.6%

  • 0.38 [0.19; 0.72]

  • 0.03 [0.00; 0.47]

  • 0.48 [0.35; 0.67]

  • 0.73 [0.61; 0.86]

  • 0.07 [0.00; 0.97]

  • 0.41 [0.21; 0.79]

graphic file with name 1678-9946-rimtsp-62-S1678-9946202062052-e02.jpg
Heterogeneity: I2 =85%, t2 = 0.3255, p = <0.01